Target Name: OR6C70
NCBI ID: G390327
Review Report on OR6C70 Target / Biomarker Content of Review Report on OR6C70 Target / Biomarker
OR6C70
Other Name(s): Olfactory receptor 6C70 | Olfactory receptor family 6 subfamily C member 70 | O6C70_HUMAN | olfactory receptor family 6 subfamily C member 70

OR6C70: A GPCR Molecule Implicated in Diseases and Olfactory Effects

Olfactory receptor 6C70 (OR6C70) is a G protein-coupled receptor (GPCR) that is expressed in the mouse olfactory bud epithelial cells and human olfactory epithelial cells. It is an important olfactory receptor and plays an important role in sensing odors. The human OR6C70 receptor gene is located on human chromosome 6p21.1.

In recent years, researchers have conducted in-depth studies on OR6C70 and found that it is related to many diseases, including neurological diseases, tumors, and diabetes. Additionally, OR6C70 has been implicated in the olfactory effects of drugs, such as scent therapies and perfumes. Therefore, OR6C70 has become an attractive drug target and potential biomarker.

In terms of neurological diseases, OR6C70 is closely related to the occurrence and development of many diseases, such as depression, Alzheimer's disease, Parkinson's disease and epilepsy. Studies have shown that the activation status of OR6C70 is closely related to the survival and apoptosis of neurons. In addition, OR6C70 is also closely related to neuronal action potentials and synaptic transmission. Therefore, OR6C70 is considered a promising target for the treatment of neurological diseases.

In terms of tumors, OR6C70 is closely related to the occurrence and development of many tumors, such as lung cancer, breast cancer, and prostate cancer. Studies have shown that the activation status of OR6C70 is closely related to the growth and invasion ability of tumor cells. In addition, OR6C70 is also closely related to the apoptosis and proliferation control of tumor cells. Therefore, OR6C70 is considered a promising target for tumor treatment.

In terms of diabetes, OR6C70 is closely related to the occurrence and development of diabetes. Studies have shown that the activation state of OR6C70 is closely related to blood sugar levels and insulin sensitivity in diabetic patients. In addition, OR6C70 is also closely associated with the risk of complications and death in patients with diabetes. Therefore, OR6C70 is considered a promising target for the treatment of diabetes.

In terms of the olfactory effects of drugs, OR6C70 is also closely related to the smell and effects of drugs. For example, odor therapy can improve patients' olfactory function by activating OR6C70. In addition, perfumes can also enhance scent by activating OR6C70. Therefore, OR6C70 is of great significance in the olfactory effects of drugs.

In summary, OR6C70 is a very important drug target and biomarker. It is closely related to the occurrence and development of many diseases, including neurological diseases, tumors and diabetes. In addition, OR6C70 is also related to the olfactory effects of drugs. Therefore, OR6C70 is a promising therapeutic target. Future studies can delve into the biological functions of OR6C70 and its relationship with disease. Through these studies, an important theoretical basis can be provided for the development of new treatment methods and diagnostic tools.

Protein Name: Olfactory Receptor Family 6 Subfamily C Member 70

Functions: Odorant receptor

The "OR6C70 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR6C70 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1